Form 4: Organogenesis Holdings Inc. Executive Brian Grow Reports Stock Transaction
SEC Form 4 Filing
Brian Grow, Chief Commercial Officer of Organogenesis Holdings Inc., reports the disposition of 1,977 shares of Class A Common Stock on April 1, 2024, to cover tax obligations.
Summary
- On April 1, 2024, Brian Grow, the Chief Commercial Officer of Organogenesis Holdings Inc., disposed of 1,977 shares of Class A Common Stock.
- The transaction was executed at a price of $2.8 per share.
- This disposition was related to covering tax obligations.
- Following the transaction, Grow directly owns 520,809 shares of Organogenesis Holdings Inc.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing related to an executive's stock transaction. It doesn't inherently convey positive or negative sentiment, as it's a routine disclosure.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and directors. This filing indicates a transaction by a key executive at Organogenesis Holdings Inc.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a small number of shares being sold by an executive to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 04/01/2024 | Date of the stock transaction (disposal of shares). |
| 04/03/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.